Vascular Therapies posts results of Phase 3 ACCESS 2 trial of Sirogen in ESRD patients
The ACCESS 2 trial, a Phase 3 study with 136 participants, evaluated the Sirolimus eluting Collagen implant (Sirogen) in patients undergoing arteriovenous fistula surgery. Results were first posted on ClinicalTrials.gov on October 6, 2026, after the study's primary completion on March 18, 2025.
Primary source
ClinicalTrials.gov results record, October 6, 2026
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
Read the source: A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation